4 Undervalued Stocks with Strong Growth Prospects for Maximum Returns

Four stocks, Royal Gold, NVIDIA, Biocept, and Akebia Therapeutics, have been identified as strong investments based on their growth history, superior stock performance, and undervalued prices. Royal Gold benefits from solid streaming agreements and a strong balance sheet, while NVIDIA's growth is driven by the increasing demand for AI and high-performance computing. Biocept and Akebia Therapeutics have shown consistent earnings surprises and a strong potential for growth.